Wanbury spurts after Tanuku facility clears ANVISA inspection with zero observations

The inspection was conducted from 16 December to 20 December 2024, confirmed the facility's strict adherence to Current Good Manufacturing Practices (cGMP).

As a result, ANVISA has granted the facility the Good Manufacturing Practices (GMP) Certificate.

Wanbury is a pharmaceutical company with a presence in the global API market and domestic branded formulations.

The company's consolidated net profit declined 88.12% to Rs 1.22 crore as revenues fell by 8.28% to Rs 133.45 crore in Q3 FY25 as compared with Q3 FY24.

Powered by Capital Market - Live News